Bright Minds Biosciences Inc.
DRUG
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.60% | 242.48% | 9.11% | 57.98% | -2.74% |
| Total Receivables | -5.28% | 123.32% | 23.60% | 48.37% | 23.02% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.24% | 16.29% | 27.21% | 36.56% | 85.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.64% | 238.73% | 9.39% | 57.64% | -2.00% |
|
|
|||||
| Total Current Assets | -2.64% | 238.73% | 9.39% | 57.64% | -2.00% |
| Net Property, Plant & Equipment | -28.46% | -22.62% | -16.42% | -15.01% | -12.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -2.65% | 238.47% | 9.36% | 57.46% | -2.02% |
|
|
|||||
| Total Accounts Payable | -36.17% | 149.71% | -14.98% | 227.88% | -2.35% |
| Total Accrued Expenses | -7.61% | 88.89% | -88.17% | 3,217.09% | 85.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -21.69% | -8.24% | 5.93% | 5.93% | 5.91% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -34.96% | 138.49% | -31.16% | 277.95% | -0.05% |
|
|
|||||
| Total Current Liabilities | -34.96% | 138.49% | -31.16% | 277.95% | -0.05% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -58.78% | -35.79% | -25.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -34.96% | 136.00% | -31.64% | 248.42% | -3.16% |
|
|
|||||
| Common Stock & APIC | -1.96% | 163.36% | 12.73% | 34.22% | 5.41% |
| Retained Earnings | -1.63% | -17.50% | -18.09% | -7.33% | -20.22% |
| Treasury Stock & Other | 17.43% | 8.90% | 25.76% | 19.24% | 50.13% |
| Total Common Equity | -2.25% | 240.30% | 10.55% | 55.00% | -2.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.25% | 240.30% | 10.55% | 55.00% | -2.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.25% | 240.30% | 10.55% | 55.00% | -2.01% |
|
|
|||||